Carian masa nyata
TopFind sedang mencari padanan terkini untuk carian anda.
Kami menyemak 59 hasil langsung untuk amgevita yuflyma hyrimoz adalimumab biosimilars dan mengecilkannya kepada 3 pilihan yang paling berbaloi dibandingkan dahulu.
Tema paling kuat dalam senarai pendek ini ialah Prescription Medicine dan Biosimilar.
Sumber: Amgen Inc.
Penerangan
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
Terbaik untuk
International patients, Uveitis treatment, Hidradenitis suppurativa care dan Ankylosing spondylitis patients
Penilaian
Sumber: Amgevita
Penerangan
A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Terbaik untuk
Rheumatoid arthritis patients, Crohn’s disease treatment, Psoriatic arthritis care dan Ulcerative colitis management
Penilaian
Sumber: Celltrion Healthcare
Penerangan
Yuflyma is an adalimumab biosimilar, classified as a biologic Disease-Modifying Antirheumatic Drug (DMARD). It is used to treat immune-mediated inflammatory diseases by targeting and neutralizing TNF-alpha, helping to alleviate symptoms in conditions like psoriasis and arthritis.
Terbaik untuk
Psoriatic arthritis, Inflammatory disease management dan Biologic DMARD users
Penilaian
| Bandingkan | Amgevita (adalimumab) | Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) | Yuflyma (Adalimumab) |
|---|---|---|---|
| Sumber | Amgen Inc. | Amgevita | Celltrion Healthcare |
| Penerangan | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. | A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. | Yuflyma is an adalimumab biosimilar, classified as a biologic Disease-Modifying Antirheumatic Drug (DMARD). It is used to treat immune-mediated inflammatory diseases by targeting and neutralizing TNF-alpha, helping to alleviate symptoms in conditions like psoriasis and arthritis. |
| Terbaik untuk | International patients, Uveitis treatment, Hidradenitis suppurativa care dan Ankylosing spondylitis patients | Rheumatoid arthritis patients, Crohn’s disease treatment, Psoriatic arthritis care dan Ulcerative colitis management | Psoriatic arthritis, Inflammatory disease management dan Biologic DMARD users |
| Tindakan | |||
| Penilaian |
Jika anda mahu bermula dengan pilihan paling seimbang, saya cadangkan:
"Amgevita (adalimumab) daripada Amgen Inc.."
Saya memilih ini kerana Amgevita provides a globally recognized biosimilar alternative for adalimumab therapy, backed by regulatory approvals in multiple major international markets.